Von Willebrand Disease laboratory diagnosis in a low middle income country

Von Willebrand Disease laboratory diagnosis in a low middle income country

Bibliographic Details
Main Authors:	O.N.S. GHALI, Hajer Mahmoudi, Fatma Ben Lakhal, Sarra Fekih Salem, Anis Fadhlaoui, Emna Gouider, Wijdene Elborgi
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Journal of Taibah University Medical Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1658361223001671

Similar Items

Inhibitor in Von Willebrand disease: Two case reports
by: Ghali Ons, et al.
Published: (2023-01-01)

Activated Partial Thromboplastin Time Clot Waveform Analysis In Hemophilia A
by: Maha Said, et al.
Published: (2023-01-01)

Bleeding phenotype in hemophilia carriers : Tunisian center experience
by: Ons Ghali, et al.
Published: (2023-01-01)

Inhibitor in people living with hemophilia B severe : A four cases report
by: Ghali Ons, et al.
Published: (2023-01-01)

Coexistence of JAK2V617F and CALR mutation in Tunisian cohort with Philadelphia-negative chronic myeloproliferative neoplasms
by: Hejer Elmahmoudi, et al.
Published: (2023-01-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021-11-01)

The relationship between von willebrand factor gene and von willebrand factor antigen levels in dogs
by: ASLAN Ö, et al.
Published: (2016-07-01)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
by: Inge Vangenechten, et al.
Published: (2020-08-01)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
by: Emmanuel J. Favaloro
Published: (2020-08-01)

A novel approach to laboratory assessment and reporting of platelet von Willebrand factor
by: Thorsten Kragh, et al.
Published: (2022-02-01)

MISDIAGNOSIS OF ACQUIRED VON WILLEBRAND DISEASE
by: AP Francisco, et al.
Published: (2023-10-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Treatment of patients with von Willebrand disease
by: Tuohy E, et al.
Published: (2011-04-01)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
by: Johan Boender, et al.
Published: (2021-03-01)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
by: Alessandra Casonato, et al.
Published: (2021-08-01)

Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review
by: Shawn X. Sun PhD, et al.
Published: (2023-06-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
by: Bauer A, et al.
Published: (2023-06-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

The Manifold Cellular Functions of von Willebrand Factor
by: Angelika Mojzisch, et al.
Published: (2021-09-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

The role of von Willebrand factor in hemostasis pathology
by: Yu. N. Avtaeva, et al.
Published: (2023-01-01)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Treatment of patients with von Willebrand disease [Erratum]
by: Tuohy E, et al.
Published: (2013-05-01)

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.
by: Peyvandi, F, et al.
Published: (2018)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021-11-01)

Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease
by: Megan C. Brown, et al.
Published: (2021-05-01)

The Prevalence of von Willebrand Disease and Significance of in Vitro Bleeding Time (PFA-100) in von Willebrand Disease Screening in the İzmir Region
by: Fatih Şap, et al.
Published: (2013-03-01)

Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.
by: Jing Dong, et al.
Published: (2012-01-01)

Assessment of Patients with von Willebrand Disease with ISTH/ BAT and PBQ Scores
by: Fatma Burcu Belen Apak, et al.
Published: (2020-02-01)

Clinical and laboratory presentation of von Willebrand disease: Experience from a single center in Saudi Arabia
by: Tarek Owaidah, MD, et al.
Published: (2023-04-01)

Aptamers Targeting Von Willebrand Factor: What and Why?
by: Roger E. G. Schutgens
Published: (2023-02-01)

In-Silico Characterization of von Willebrand Factor Bound to FVIII
by: Valentina Drago, et al.
Published: (2022-08-01)

DEEP VEIN THROMBOSIS IN PATIENT WITH VON WILLEBRAND DISEASE
by: V. A. Elykomov, et al.
Published: (2016-09-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
by: Jessica M. Heijdra, et al.
Published: (2022-08-01)

The von Willebrand factor – ADAMTS‐13 axis in malaria
by: Andrew S. O’Donnell, et al.
Published: (2022-01-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Role of von Willebrand factor in venous thromboembolic disease
by: Alison Michels, MD, PhD, et al.
Published: (2022-01-01)

Establishing reference intervals for von Willebrand factor multimers
by: Pikta Marika, et al.
Published: (2022-01-01)